Imodium Original

Loperamide, the active ingredient in Imodium Original, is an antidiarrheal presented as a tablet for oral use. It is indicated for acute nonspecific diarrhea, chronic diarrhea associated with inflammatory bowel disease, and irritable bowel syndrome with diarrhea, helping to reduce stool frequency and liquidity. GNH USA supplies Imodium Original as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imodium Original is an antidiarrheal that acts on intestinal motility and fluid absorption. - Acute nonspecific diarrhea: reduces stool frequency and liquidity, providing symptomatic relief. - Chronic diarrhea associated with inflammatory bowel disease: helps control ongoing diarrheal symptoms. - Irritable bowel syndrome with diarrhea: alleviates diarrheal episodes and improves bowel regularity.

Adverse reactions may occur with any medication and should be monitored.

Common Side Effects: - Constipation - Abdominal cramps - Nausea - Dizziness

Serious or Rare Side Effects: - Severe constipation or intestinal obstruction - Allergic reactions such as rash or angioedema - Toxic megacolon (rare but serious)

Use Imodium Original according to professional guidance and avoid exceeding recommended duration. - Indication limitation: Do not use for infectious diarrhea caused by invasive bacteria or parasites. - Hypersensitivity: Avoid in patients with known allergy to loperamide or excipients. - Hepatic impairment: Use with caution, as metabolism may be reduced. - Monitor for constipation: Discontinue if severe constipation develops. - Store at ambient temperature: keep in the original pack, protect from moisture.

Loperamide may interact with other medicines, requiring attention to potential effects.

Major Interactions (Avoid): - Potent CYP3A4 inhibitors (e.g., ketoconazole) may increase loperamide plasma levels. - Concurrent use with other antidiarrheal agents can cause additive constipation. - Co‑administration with quinidine may raise the risk of cardiac arrhythmias.

Moderate Interactions (Monitor Closely): - Opioid analgesics may enhance central opioid effects. - CYP3A4 inducers (e.g., rifampin) may reduce loperamide efficacy. - Sedatives or CNS depressants may increase drowsiness when combined.